Hefei Lifeon Pharmaceutical Company Description

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients in China and internationally.

The company offers active pharmaceutical ingredients, which includes felodipine, urea, paeonol, doxazosin mesylate, prilocaine, nifedipine, azilsartan kamedoxomil, methylphenidate hydrochloride, dexmethylphenidate HCL, dioctyl sulfosuccinate sodium salt, and DMSA.

It also provides intermediate products, such as sodium paeonolsilate, methy2-(2,3-dichlorobenzylidine)-acetoacetate, 3-mercapto-1-propanol, mercaptosuccinic acid and DMPS monohydrate.

In addition, it offers nifedipine controlled, doxazosin mesylate, felodipine, trimetazidine dihydrochloride prolonged, and paliperidone release tablets; venlafaxine, methylphenidate, and oxycodone hydrochloride prolonged release tablets; chinese medicines; and proxymetacaine hydrochloride, bendazac lysine, timolol maleate, gatifloxacin, jinzhen, pemirolast potassium, and compound dextran 70 eye drops.

Further, it provides paeonol ointment, kecuo yintong gel, compound tujingpi gel, metformin and glipizide tablets, and itraconazole and armillarisin oral solution.

The company was incorporated in 2002 and is based in Hefei, China.